DRUG TEST 3 (62 Marks)

ORAL GLUCOSE POWDER/ GEL

1. DESCRIPTION (2)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

PHARMACOLOGICAL ACTION (1)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

ADVERSE EFFECTS (1)

___________________________________________________________________________
___________________________________________________________________________

INDICATIONS (2)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

CONTRA-INDICATIONS (2)

___________________________________________________________________________
___________________________________________________________________________

PRECAUTIONS (2)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

1
DOSAGE AND ADMINISTRATION (3)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

2. NITROUS OXIDE and OXYGEN (ENTONOX®)

DESCRIPTION (2)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

PHARMACOLOGICAL ACTION(6)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

PHARMACO-KINETICS (4)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

ADVERSE EFFECTS (3)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

2
INDICATIONS (5)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

CONTRA-INDICATIONS (8)

• _______________________________________

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

• _________________________________________

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

• ___________________________________________

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

PRECAUTIONS (5)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

3
 PACKAGING (1)

___________________________________________________________________________
___________________________________________________________________________

DOSAGE AND ADMINISTRATION (5)

___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

3. ACTIVATED CHARCOAL

DESCRIPTION (2)

• Classification: _________________________________________________________
• Schedule: ____________________________________________________________

PHARMACOLOGICAL ACTION (1)

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________

4
 4. Oxygen (7)

PRECAUTIONS

______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________

5
6